Clinical trial · Interventional
Effect of Geranium Inhalation Aromatherapy on Pain and Blood Pressure in Cancer Patients Undergoing Chemotherapy
Effect of Geranium Inhalation Aromatherapy on Reducing Pain and Blood Pressure Among Indonesian Cancer Patients Undergoing Chemotherapy: A Randomized Controlled Trial
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This randomized controlled trial aims to examine the effect of geranium inhalation aromatherapy on pain and blood pressure among Indonesian cancer patients undergoing intravenous chemotherapy. A total of 90 participants under the age of 65 with normal BMI will be enrolled and randomly assigned to either an intervention group or a control group. The intervention group will receive geranium essential oil inhalation using three drops applied to cotton and inhaled for 15 minutes during chemotherapy sessions, while the control group will receive usual care without aromatherapy. Pain intensity will be measured using the Visual Analog Scale (VAS), and blood pressure will be recorded using a standard digital blood pressure monitor before and after the intervention. This study aims to evaluate whether geranium aromatherapy can be feasibly implemented as a complementary supportive therapy during chemotherapy. Study Started Date after January 18, 2017
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Blood Pressure Changes in Cancer Patients | — | UNRESOLVED | — |
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Chemotherapy Induced Pain | — | UNRESOLVED | — |
| Chemotherapy Side Effects | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Geranium Inhalation Aromatherapy | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Geranium Inhalation Aromatherapy
- description
- Participants in this arm received geranium inhalation aromatherapy during their chemotherapy session. Three drops of geranium essential oil were placed on a piece of cotton and inhaled for 15 minutes during chemotherapy, administered twice per month. Pain and blood pressure were assessed before and after the intervention
- interventionNames
- Other: Geranium Inhalation Aromatherapy
- type
- NO_INTERVENTION
- label
- Usual Care / No Aromatherapy
- description
- Participants in this arm received standard chemotherapy care without any aromatherapy intervention. They underwent the same assessment procedures as the intervention group, including pre- and post-treatment measurements of pain and blood pressure, but no essential oil was administered
Primary outcomes (1)
- measure
- Change in Pain Intensity (Visual Analog Scale - VAS)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion: 1. Cancer patients undergoing intravenous chemotherapy (regimen 1 / series 1) 2. Age less than 65 years 3. Body Mass Index (BMI) between 18.5 and 22.9 kg/m². 4. Willing to participate and able to provide informed consent. Exlusion: 1. Patients with conditions affecting the sense of smell (e.g., severe nasal obstruction or anosmia). 2. Patients with known allergies to essential oils or plant-based aromatherapy products. 3. Patients experiencing acute medical emergencies or unstable hemodynamic conditions during chemotherapy. 4. Patients who withdraw consent at any stage of the study.
References
Publications (0)
Data not yet available